BMS-200475, a novel carbocyclic 2'-deoxyguanosine analog with potent and selective anti-hepatitis B virus activity in vitro

被引:129
作者
Bisacchi, GS
Chao, ST
Bachard, C
Daris, JP
Innaimo, S
Jacobs, GA
Kocy, O
Lapointe, P
Martel, A
Merchant, Z
Slusarchyk, WA
Sundeen, JE
Young, MG
Colonno, R
Zahler, R
机构
[1] Bristol-Myers Squibb P., Princeton, NJ 08543-4000
[2] Bristol-Myers Squibb P., Candiac, Que. J5R 1J1
[3] Bristol-Myers Squibb P., Wallingford, CT 06492-7660
关键词
D O I
10.1016/S0960-894X(96)00594-X
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
BMS-200475, a novel carbocyclic analog of 2'-deoxyguanosine, is a potent inhibitor of hepatitis B virus in vitro (ED(50)=3 nM) with relatively low cytotoxicity (CC50=21-120 mu M). A practical 10-step asymmetric synthesis was developed affording BMS-200475 in 18% overall chemical yield and >99% optical purity. The enantiomer of EMS-200475 as well as the adenine, thymine, and iodouracil analogs are much less active. (C) 1997, Elsevier Science Ltd.
引用
收藏
页码:127 / 132
页数:6
相关论文
共 20 条